Statement on the safety of synthetic zeaxanthin as an ingredient in food supplements

EFSA Journal

Volumn 10, Issue 10, 2012, Pages

[No Author Info available]

Author keywords

carotenoids; novel food; safety; xanthophylls; Zeaxanthin

Indexed keywords

EID: 85048603758     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2012.2891     Document Type: Article

References (38)

1. Albert GI, Hoeller U, Schierle J, Neuringer M, Johnson EJ and Schalch W, 2008. Metabolism of lutein and zeaxanthin in rhesus monkeys: identification of (3R,6′R)- and (3R,6's)-3′-dehydro-lutein as common metabolites and comparison to humans. Comp Biochem Physiol B Biochem Mol Biol, 151, 70–78.
2. Amengual J, Lobo GP, Golczak M, Li HN, Klimova T, Hoppel CL, Wyss A, Palczewski K and von Lintig J, 2011. A mitochondrial enzyme degrades carotenoids and protects against oxidative stress. FASEB J, 25, 948–959.
3. Beutner S, Bloedorn B, Frixel S, Hernández Blanco I, Hoffmann T, Martin HD, Mayer B, P. N, Ruck C, Schmidt M, Schülke I, Sell S, Ernst H, Haremza S, Sies H, Stahl W and Walsh R, 2001. Quantitative assessment of antioxidant properties of natural colorants and phytochemicals: carotenoids, flavonoids, phenols and indigoids. The role of β-carotene in antioxidant functions. Journal of the Science of Food and Agriculture, 81, 559–568.
4. Carboni G, Forma G, Jennings BJ and Iannaccone A, 2011. Effects of Zeaxanthin (Zx) Supplementation on Macular Pigment Optical Density (MPOD). ARVO Meeting Abstracts, 52, 3622.
5. Cook NR, Le IM, Manson JE, Buring JE and Hennekens CH, 2000. Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States). Cancer Causes Control, 11, 617–626.
6. o-2500072, 31 March 2006.
7. EFSA Panel on Dietetic Products Nutrition and Allergies, 2008. Scientific Opinion of the Panel on Dietetic Products Nutrition and Allergies on a request from the European Commission on the safety of ‘Zeaxanthin as an ingredient in food supplements’. EFSA Journal, 728, 721–728.
8. EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS), 2010. Scientific Opinion on the reevaluation of lutein (E 161b) as a food additive on request of the European Commission. EFSA Journal, 8(7): 1678.
9. Eroglu A, Hruszkewycz DP, Curley RW, Jr. and Harrison EH, 2010. The eccentric cleavage product of beta-carotene, beta-apo-13-carotenone, functions as an antagonist of RXRalpha. Arch Biochem Biophys, 504, 11–16.
10. Forma G, Carboni G, Jennings BJ and Iannaccone A, 2011. Measures Of Macular Function After Dietary Supplementation With Zeaxanthin (Zx). ARVO Meeting Abstracts, 52, 3637.
11. Gradelet S, Leclerc J, Siess MH and Astorg PO, 1996. beta-Apo-8'-carotenal, but not beta-carotene, is a strong inducer of liver cytochromes P4501A1 and 1A2 in rat. Xenobiotica, 26, 909–919.
12. Hartmann D, Thurmann PA, Spitzer V, Schalch W, Manner B and Cohn W, 2004. Plasma kinetics of zeaxanthin and 3′-dehydro-lutein after multiple oral doses of synthetic zeaxanthin. Am J Clin Nutr, 79, 410–417.
13. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W and Peto R, 1996. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med, 334, 1145–1149.
14. Hu KQ, Liu C, Ernst H, Krinsky NI, Russell RM and Wang XD, 2006. The biochemical characterization of ferret carotene-9′,10′-monooxygenase catalyzing cleavage of carotenoids in vitro and in vivo. J Biol Chem, 281, 19327–19338.
15. Huang LL, Coleman HR, Kim J, de Monasterio F, Wong WT, Schleicher RL, Ferris FL, 3rd and Chew EY, 2008. Oral supplementation of lutein/zeaxanthin and omega-3 long chain polyunsaturated fatty acids in persons aged 60 years or older, with or without AMD. Invest Ophthalmol Vis Sci, 49, 3864–3869.
16. Liu C, Wang XD, Bronson RT, Smith DE, Krinsky NI and Russell RM, 2000. Effects of physiological versus pharmacological beta-carotene supplementation on cell proliferation and histopathological changes in the lungs of cigarette smoke-exposed ferrets. Carcinogenesis, 21, 2245–2253.
17. Liu C, Russell RM and Wang XD, 2003. Exposing ferrets to cigarette smoke and a pharmacological dose of beta-carotene supplementation enhance in vitro retinoic acid catabolism in lungs via induction of cytochrome P450 enzymes. J Nutr, 133, 173–179.
18. Liu C, Wang XD, Mucci L, Gaziano JM and Zhang SM, 2009. Modulation of lung molecular biomarkers by beta-carotene in the Physicians' Health Study. Cancer, 115, 1049–1058.
19. Liu C, Bronson RT, Russell RM and Wang XD, 2011. beta-Cryptoxanthin supplementation prevents cigarette smoke-induced lung inflammation, oxidative damage, and squamous metaplasia in ferrets. Cancer Prev Res (Phila), 4, 1255–1266.
20. Mannisto S, Smith-Warner SA, Spiegelman D, Albanes D, Anderson K, van den Brandt PA, Cerhan JR, Colditz G, Feskanich D, Freudenheim JL, Giovannucci E, Goldbohm RA, Graham S, Miller AB, Rohan TE, Virtamo J, Willett WC and Hunter DJ, 2004. Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies. Cancer Epidemiol Biomarkers Prev, 13, 40–48.
21. Martin HD, Ruck C, Schmidt M, Sell S, Beutner S, Mayer B and Walsh R, 1999. Chemistry of carotenoid oxidation and free radical reactions. Pure and Applied Chemistry, 71, 2253–2262.
22. Martin MT, Mendez E, Corum DG, Judson RS, Kavlock RJ, Rotroff DM and Dix DJ, 2009. Profiling the reproductive toxicity of chemicals from multigeneration studies in the toxicity reference database. Toxicol Sci, 110, 181–190.
23. McNulty HP, Byun J, Lockwood SF, Jacob RF and Mason RP, 2007. Differential effects of carotenoids on lipid peroxidation due to membrane interactions: X-ray diffraction analysis. Biochim Biophys Acta, 1768, 167–174.
24. Mein JR, Dolnikowski GG, Ernst H, Russell RM and Wang XD, 2011. Enzymatic formation of apo-carotenoids from the xanthophyll carotenoids lutein, zeaxanthin and beta-cryptoxanthin by ferret carotene-9′,10′-monooxygenase. Arch Biochem Biophys, 506, 109–121.
25. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FLJr., Valanis B, Williams JHJr., Barnhart S, Cherniack MG, Brodkin CA and Hammar S, 1996. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst, 88, 1550–1559.
26. Ravikrishnan R, Rusia S, Ilamurugan G, Salunkhe U, Deshpande J, Shankaranarayanan J, Shankaranarayana ML and Soni MG, 2011. Safety assessment of lutein and zeaxanthin (Lutemax 2020): subchronic toxicity and mutagenicity studies. Food Chem Toxicol, 49, 2841–2848.
27. Richer SP, Stiles W, Graham-Hoffman K, Levin M, Ruskin D, Wrobel J, Park DW and Thomas C, 2011. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973. Optometry, 82, 667–680 e666.
28. Satia JA, Littman A, Slatore CG, Galanko JA and White E, 2009. Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study. Am J Epidemiol, 169, 815–828.
29. Schalch W, Cohn W, Barker FM, Kopcke W, Mellerio J, Bird AC, Robson AG, Fitzke FF and van Kuijk FJ, 2007. Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin - the LUXEA (LUtein Xanthophyll Eye Accumulation) study. Arch Biochem Biophys, 458, 128–135.
30. Siems WG, Sommmerburg O and van Kuijk FJ, 1999. Lycopene and beta-carotene decompose more rapidly than lutein and zeaxanthin upon exposure to various pro-oxidants in vitro. Biofactors, 10, 105–113.
31. Stringham JM and Hammond BR, 2008. Macular pigment and visual performance under glare conditions. Optom Vis Sci, 85, 82–88.
32. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med, 330, 1029–1035.
33. van de Kraats J, Kanis MJ, Genders SW and van Norren D, 2008. Lutein and zeaxanthin measured separately in the living human retina with fundus reflectometry. Invest Ophthalmol Vis Sci, 49, 5568–5573.
34. van Vliet T, van Schaik F, Schreurs WH and van den Berg H, 1996. In vitro measurement of beta-carotene cleavage activity: methodological considerations and the effect of other carotenoids on beta-carotene cleavage. Int J Vitam Nutr Res, 66, 77–85.
35. Wang XD, Krinsky NI, Marini RP, Tang G, Yu J, Hurley R, Fox JG and Russell RM, 1992. Intestinal uptake and lymphatic absorption of beta-carotene in ferrets: a model for human beta-carotene metabolism. Am J Physiol, 263, G480–486.
36. Wang XD, Liu C, Bronson RT, Smith DE, Krinsky NI and Russell M, 1999. Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke. J Natl Cancer Inst, 91, 60–66.
37. Wright ME, Groshong SD, Husgafvel-Pursiainen K, Genova E, Lucia MS, Wolff H, Virtamo J and Albanes D, 2010. Effects of beta-carotene supplementation on molecular markers of lung carcinogenesis in male smokers. Cancer Prev Res (Phila), 3, 745–752.
38. Xiang J, Nagaya T, Huang XE, Kuriki K, Imaeda N, Tokudome Y, Sato J, Fujiwara N, Maki S and Tokudome S, 2008. Sex and seasonal variations of plasma retinol, alpha-tocopherol, and carotenoid concentrations in Japanese dietitians. Asian Pac J Cancer Prev, 9, 413–416.